|
NADK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.706800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.784800E-01 |
| Normal-vs-Stage2 |
7.675200E-01 |
| Normal-vs-Stage3 |
4.339800E-01 |
| Normal-vs-Stage4 |
6.169400E-01 |
| Stage1-vs-Stage2 |
4.294000E-01 |
| Stage1-vs-Stage3 |
7.025400E-01 |
| Stage1-vs-Stage4 |
8.723200E-01 |
| Stage2-vs-Stage3 |
3.847000E-01 |
| Stage2-vs-Stage4 |
5.714600E-01 |
| Stage3-vs-Stage4 |
9.394600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.913000E-01 |
| Normal-vs-AfricanAmerican |
7.732000E-01 |
| Normal-vs-Asian |
9.276600E-01 |
| Caucasian-vs-AfricanAmerican |
4.546600E-01 |
| Caucasian-vs-Asian |
9.702600E-01 |
| AfricanAmerican-vs-Asian |
8.240000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.798600E-01 |
| Normal-vs-Female |
5.930000E-01 |
| Male-vs-Female |
5.033800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.074200E-01 |
| Normal-vs-Extreme_Weight |
5.452400E-01 |
| Normal-vs-Obese |
6.214600E-01 |
| Normal-vs-Extreme_Obese |
8.351200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.540200E-01 |
| Normal_Weight-vs-Obese |
8.450200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.792400E-01 |
| Extreme_Weight-vs-Obese |
8.974000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.778200E-01 |
| Obese-vs-Extreme_Obese |
9.286200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.376370E-01 |
| Normal-vs-Age(41-60Yrs) |
8.284200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.182600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.496000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.549440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.670000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.159600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.903600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.869000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.761200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.545400E-01 |
| Normal-VS-Type2 PRCC |
2.768400E-01 |
| Normal-VS-KIRP CIMP |
1.764960E-01 |
| Normal-VS-Unclassified PRCC |
3.901600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.921900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.561600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.292000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.354300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.171700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.473400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.251600E-01 |
| Normal-vs-N1 |
7.740200E-01 |
| Normal-vs-N2 |
9.494800E-01 |
| N0-vs-N1 |
5.723200E-01 |
| N0-vs-N2 |
6.463600E-01 |
| N1-vs-N2 |
8.555200E-01 |
|
|
